Rhabdomyolysis, when observed with high-dose interferon-alfa (HDI) therapy, does not always exclude resumption of HDI.
van Londen
G J
GJ
Mascarenhas
B
B
Kirkwood
J M
JM
D000328:Adult; D000075202:Contraindications; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy; D012206:Rhabdomyolysis / Q000139:chemically induced*
D016898:Interferon-alpha